We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Introduces Coxsackie A6/A10 Nucleic Acid Detection Kit

By LabMedica International staff writers
Posted on 02 Aug 2022

Hand, foot, and mouth disease (HFMD) is an infectious disease caused by enteroviruses and is characterized by fever and vesicular eruptions on the hands feet and mouth. More...

There are more than 20 kinds of enteroviruses that cause HFMD. Among them, the enterovirus 71 and Coxsackie A 16 are the most common pathogens. However, in recent years, non-EV71 and non-CA16 enteroviruses have also become important HFMD causing pathogens, among which the Coxsackievirus group A Type 6 (CA) and Coxsackievirus Group A Type 10 (CA10) are important pathogens. Now, a newly-launched nucleic acid detection kit can assist in the diagnosis and treatment of Coxsackie A6/A10 virus infection.

Tianlong Science and Technology (Shaanxi, China) has introduced the Coxsackie A6/A10 Nucleic Acid Detection Kit for the qualitative detection of Coxsackie A6/A10 Virus nucleic acid. The kit enables the detection and differentiation of Coxsackie A6/A10, the important HFMD causing pathogen, using the Real Time Reverse Transcription Polymerase Chain Reaction (Real-time RT-PCR) method. Its innovative 3-in-1 tube PCR with reaction solution, primers and PCR enzymes in one tube, minimizes the time required for sample addition and enables PCR detection within 40 minutes. The Coxsackie A6/A10 Nucleic Acid Detection Kit is CE marked, making it accessible to more countries.

Related Links:
Tianlong Science and Technology 


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.